1 January 2024 false No description of principal activity Taxfiler 2024.6 05169215 business:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05169215 2023-12-31 05169215 2024-01-01 2024-12-31 05169215 business:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 05169215 business:FilletedAccounts 2024-01-01 2024-12-31 05169215 2024-12-31 05169215 business:Director1 2024-01-01 2024-12-31 05169215 business:Director2 2024-01-01 2024-12-31 05169215 business:RegisteredOffice 2024-01-01 2024-12-31 05169215 2023-12-31 05169215 core:WithinOneYear 2024-12-31 05169215 core:WithinOneYear 2023-12-31 05169215 core:ShareCapital core:PreviouslyStatedAmount 2024-12-31 05169215 core:ShareCapital core:PreviouslyStatedAmount 2023-12-31 05169215 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-12-31 05169215 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2023-12-31 05169215 core:PreviouslyStatedAmount 2024-12-31 05169215 core:PreviouslyStatedAmount 2023-12-31 05169215 business:SmallEntities 2024-01-01 2024-12-31 05169215 countries:EnglandWales 2024-01-01 2024-12-31 05169215 core:PlantMachinery 2024-01-01 2024-12-31 05169215 core:PlantMachinery 2023-12-31 05169215 core:PlantMachinery 2024-12-31 05169215 core:AfterOneYear 2024-12-31 05169215 core:AfterOneYear 2023-12-31 05169215 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure
Company Registration No. 05169215 (England and Wales)
COVISION MEDICAL TECHNOLOGIES LIMITED Unaudited accounts for the year ended 31 December 2024
COVISION MEDICAL TECHNOLOGIES LIMITED Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
COVISION MEDICAL TECHNOLOGIES LIMITED Company Information for the year ended 31 December 2024
Directors
DAYIBASI, Ugur OZKAN, Mehmet
Company Number
05169215 (England and Wales)
Registered Office
84 Brook Street Office 4.3 London London W1K 5EH England
- 3 -
COVISION MEDICAL TECHNOLOGIES LIMITED Statement of financial position as at 31 December 2024
2024
2023
Notes
£
£
Fixed assets
Investments
5
584,503
584,503
Current assets
Debtors
6
544,218
689,693
Cash at bank and in hand
18,052
11,837
562,270
701,530
Creditors: amounts falling due within one year
7
35,091
(48,669)
Net current assets
597,361
652,861
Net assets
1,181,864
1,237,364
Capital and reserves
Called up share capital
1,500,000
1,500,000
Profit and loss account
(318,136)
(262,636)
Shareholders' funds
1,181,864
1,237,364
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 12 September 2025 and were signed on its behalf by
DAYIBASI, Ugur Director Company Registration No. 05169215
- 4 -
COVISION MEDICAL TECHNOLOGIES LIMITED Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
COVISION MEDICAL TECHNOLOGIES LIMITED is a private company, limited by shares, registered in England and Wales, registration number 05169215. The registered office is 84 Brook Street, Office 4.3, London, London, W1K 5EH, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Investments
Investments in subsidiaries are measured at cost less accumulated impairment.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25%
4
Tangible fixed assets
Plant & machinery
£
Cost or valuation
At cost
At 1 January 2024
29,422
At 31 December 2024
29,422
Depreciation
At 1 January 2024
29,422
At 31 December 2024
29,422
Net book value
At 31 December 2024
-
- 5 -
COVISION MEDICAL TECHNOLOGIES LIMITED Notes to the Accounts for the year ended 31 December 2024
5
Investments
Subsidiary undertakings
£
Valuation at 1 January 2024
584,503
Valuation at 31 December 2024
584,503
The company holds 100% of the ordinary share capital of Covision Medical Technologies Sanayi, a company registered in Turkey. The company has taken the exemption from preparing consolidated financial statements as applicable under the small companies regime.
6
Debtors
2024
2023
£
£
Amounts falling due within one year
VAT
2,145
29,482
Trade debtors
386,088
504,230
Other debtors
4
-
388,237
533,712
Amounts falling due after more than one year
Amounts due from group undertakings etc.
154,981
154,981
Other debtors
1,000
1,000
155,981
155,981
7
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
(35,100)
48,659
Taxes and social security
-
1
Other creditors
9
9
(35,091)
48,669
8
Average number of employees
During the year the average number of employees was 3 (2023: 3).
- 6 -